DOI: 10.1111/cts.70712 ISSN: 1752-8054
Omics Biomarkers in Precision Oncology: From the Lens of the
ASCPT
Biomarkers and Translational Tools and Oncology Communities
Mai Mehanna, Hardik Mody, Joy C. Hsu, Julia Quintanilha, Zachary L. Taylor, Angela James, Binita Rajbanshi, Pooja Manchandani, Lakshmi Manasa Chekka ABSTRACT
Omics biomarkers comprise several molecular entities, including genomic, epigenomic, transcriptomic, proteomic, and metabolomic signatures. They play an essential role in oncology drug development and clinical settings by enabling personalized medicine. In precision oncology, validating biomarkers is a greater challenge than discovering them. The biomarkers discussed here span a wide evidentiary spectrum, from those endorsed in clinical guidelines to those that remain investigational.